MARKET

ARWR

ARWR

Arrowhead Pharma
NASDAQ
77.88
-1.16
-1.47%
Pre Market: 80.18 +2.3 +2.95% 08:22 05/14 EDT
OPEN
78.52
PREV CLOSE
79.04
HIGH
80.67
LOW
77.05
VOLUME
11.00K
TURNOVER
22.33M
52 WEEK HIGH
80.67
52 WEEK LOW
13.42
MARKET CAP
10.97B
P/E (TTM)
-36.2958
1D
5D
1M
3M
1Y
5Y
1D
Arrowhead Pharmaceuticals Is Maintained at Market Perform by Bernstein
Dow Jones · 18h ago
Arrowhead Pharmaceuticals Price Target Raised to $46.00/Share From $35.00 by Bernstein
Dow Jones · 18h ago
Bernstein Maintains Market Perform on Arrowhead Pharma, Raises Price Target to $46
Benzinga · 18h ago
ARROWHEAD PHARMACEUTICALS <ARWR.O>: BERNSTEIN RAISES TARGET PRICE TO $46 FROM $35
Reuters · 1d ago
Arrowhead price target raised to $46 from $35 at Bernstein
TipRanks · 1d ago
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Reuters · 1d ago
Arrowhead Pharmaceuticals: A True Inflection Point Has Arrived
Seeking Alpha · 1d ago
Healthcare stocks with A+ momentum investors are watching
Seeking Alpha · 1d ago
More
About ARWR
Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. The Company's therapies, using a broad portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, trigger the RNA interference (RNAi) mechanism to induce rapid, deep and durable knockdown of target genes. Its Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. It is focused on various therapeutic areas, such as cardiometabolic, pulmonary, liver, neuromuscular and others. It has over 18 discovered drug candidates in clinical trials ranging from early stage (Phase I) to late stage (Phase III). The Company's pipeline products include plozasiran, zodasiran, olpasiran, ARO-RAGE, SRP-1002, GSK4532990, fazirsiran, daplusiran/tomligisiran, ARO-CFB, ARO-INHBE, ARO-C3, ARO-PNPLA3, SRP-1001 (ARO-DUX4), SRP-1003 (ARO-DM1), SRP-1004 (ARO-ATXN2), and others.

Webull offers Arrowhead Pharmaceuticals Inc stock information, including NASDAQ: ARWR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARWR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARWR stock methods without spending real money on the virtual paper trading platform.